Page last updated: 2024-08-23

bezafibrate and Heart Failure

bezafibrate has been researched along with Heart Failure in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glukhov, AI; Javadov, S; Khuchua, Z; Strauss, AW	1
Behar, S; Benderly, M; Eisen, A; Goldbourt, U; Haim, M	1
Adler, Y; Behar, S; Boyko, V; Fisman, EZ; Goldberg, I; Inoue, T; Matas, Z; Node, K; Schwammenthal, E; Tenenbaum, A	1
Behar, S; Boyko, V; Fisman, EZ; Leor, J; Mandelzweig, L; Motro, M; Tenenbaum, A	1

Reviews

1 review(s) available for bezafibrate and Heart Failure

Article	Year
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. International journal of molecular sciences, 2018, Nov-04, Volume: 19, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Bezafibrate; Cardiomyopathies; Cardiotonic Agents; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Heart Failure; Humans; Hypolipidemic Agents; Lipid Metabolism; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Signal Transduction	2018

Article

Year

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.

International journal of molecular sciences, 2018, Nov-04, Volume: 19, Issue:11

Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Bezafibrate; Cardiomyopathies; Cardiotonic Agents; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Heart Failure; Humans; Hypolipidemic Agents; Lipid Metabolism; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Signal Transduction

2018

Trials

1 trial(s) available for bezafibrate and Heart Failure

Article	Year
Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease. American heart journal, 2014, Volume: 167, Issue:5 Topics: Age Factors; Aged; Bezafibrate; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Incidence; Inflammation; Israel; Leukocyte Count; Male; Middle Aged; Risk Factors; Time Factors	2014

Article

Year

Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.

American heart journal, 2014, Volume: 167, Issue:5

Topics: Age Factors; Aged; Bezafibrate; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Incidence; Inflammation; Israel; Leukocyte Count; Male; Middle Aged; Risk Factors; Time Factors

2014

Other Studies

2 other study(ies) available for bezafibrate and Heart Failure

Article	Year
Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment. Cardiovascular diabetology, 2009, Jan-28, Volume: 8 Topics: Aged; Bezafibrate; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Randomized Controlled Trials as Topic; Severity of Illness Index	2009
Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis. Cardiology, 2003, Volume: 100, Issue:4 Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Bezafibrate; Cause of Death; Clinical Trials as Topic; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Follow-Up Studies; Heart Failure; Humans; Israel; Male; Mathematical Computing; Middle Aged; Myocardial Infarction; Patient Selection; Risk Factors	2003

Article

Year

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.

Cardiovascular diabetology, 2009, Jan-28, Volume: 8

Topics: Aged; Bezafibrate; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Randomized Controlled Trials as Topic; Severity of Illness Index

2009

Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis.

Cardiology, 2003, Volume: 100, Issue:4

Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Bezafibrate; Cause of Death; Clinical Trials as Topic; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Follow-Up Studies; Heart Failure; Humans; Israel; Male; Mathematical Computing; Middle Aged; Myocardial Infarction; Patient Selection; Risk Factors

2003